Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.breast.2020.11.015 http://scihub22266oqcxt.onion/10.1016/j.breast.2020.11.015 33285400!7687359!33285400     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33285400&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Breast 2021 ; 55 (?): 1-6 Nephropedia Template TP {{tp|p=33285400|t=2021. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland |pdf=|usr=}}{{33285400}} gab.com Text A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland JO: Breast http://www.kidney.de/pget.php?&tw=1&pmid=33285400 #FOAvip INTRODUCTION: In order to minimise the risk of breast cancer patients for COVID-19 infection related morbidity and mortality prioritisation of care has utmost importance since the onset of the pandemic. However, COVID-19 related risk in patients undergoing breast cancer surgery has not been studied yet. We evaluated the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland region. METHODS: A prospective cohort study of patients having breast cancer surgery was carried out in a geographical region during the first eight weeks of the hospital lockdown and outcomes were compared to the regional cancer registry data of pre-COVID-19 patients of the same units (n = 1415). RESULTS: 188 operations were carried out in 179 patients. Tumour size was significantly larger in patients undergoing surgery during hospital lockdown than before (cT3-4: 16.8% vs. 7.4%; p < 0.001; pT2 - pT4: 45.5% vs. 35.6%; p = 0.002). ER negative and HER-2 positive rate was significantly higher during lockdown (ER negative: 41.3% vs. 17%, p < 0.001; HER-2 positive: 23.4% vs. 14.8%; p = 0.004). While breast conservation rate was lower during lockdown (58.6% vs. 65%; p < 0.001), level II oncoplastic conservation was significantly higher in order to reduce mastectomy rate (22.8% vs. 5.6%; p < 0.001). No immediate reconstruction was offered during lockdown. 51.2% had co-morbidity, and 7.8% developed postoperative complications in lockdown. There was no peri-operative COVID-19 infection related morbidity or mortality. CONCLUSION: breast cancer can be safely provided during COVID-19 pandemic in selected patients. Twit Text FOAVip A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland ????Breast http://www.kidney.de/pget.php?&tw=1&pmid=33285400 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33285400 #FOAvip English Wikipedia <ref>{{Cite pmid|33285400}}</ref> A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland #MMPMID33285400 Romics L; Doughty J; Stallard S; Mansell J; Blackhall V; Lannigan A; Elgammal S; Reid J; McGuigan MC; Savioli F; Tovey S; Murphy D; Reid I; Malyon A; McIlhenny J; Wilson C Breast 2021[Feb]; 55 (?): 1-6 PMID33285400show ga INTRODUCTION: In order to minimise the risk of breast cancer patients for COVID-19 infection related morbidity and mortality prioritisation of care has utmost importance since the onset of the pandemic. However, COVID-19 related risk in patients undergoing breast cancer surgery has not been studied yet. We evaluated the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland region. METHODS: A prospective cohort study of patients having breast cancer surgery was carried out in a geographical region during the first eight weeks of the hospital lockdown and outcomes were compared to the regional cancer registry data of pre-COVID-19 patients of the same units (n = 1415). RESULTS: 188 operations were carried out in 179 patients. Tumour size was significantly larger in patients undergoing surgery during hospital lockdown than before (cT3-4: 16.8% vs. 7.4%; p < 0.001; pT2 - pT4: 45.5% vs. 35.6%; p = 0.002). ER negative and HER-2 positive rate was significantly higher during lockdown (ER negative: 41.3% vs. 17%, p < 0.001; HER-2 positive: 23.4% vs. 14.8%; p = 0.004). While breast conservation rate was lower during lockdown (58.6% vs. 65%; p < 0.001), level II oncoplastic conservation was significantly higher in order to reduce mastectomy rate (22.8% vs. 5.6%; p < 0.001). No immediate reconstruction was offered during lockdown. 51.2% had co-morbidity, and 7.8% developed postoperative complications in lockdown. There was no peri-operative COVID-19 infection related morbidity or mortality. CONCLUSION: breast cancer can be safely provided during COVID-19 pandemic in selected patients. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Breast Carcinoma In Situ/pathology/surgery[MESH] |Breast Neoplasms/pathology/*surgery[MESH] |COVID-19/*epidemiology[MESH] |Carcinoma, Ductal, Breast/pathology/surgery[MESH] |Carcinoma, Intraductal, Noninfiltrating/pathology/surgery[MESH] |Carcinoma, Lobular/pathology/surgery[MESH] |Cohort Studies[MESH] |Cross Infection/*epidemiology[MESH] |Female[MESH] |Humans[MESH] |Mastectomy, Segmental/methods/statistics & numerical data[MESH] |Mastectomy/*methods/statistics & numerical data[MESH] |Middle Aged[MESH] |Neoplasm Staging[MESH] |Postoperative Complications/*epidemiology[MESH] |Prospective Studies[MESH] |SARS-CoV-2[MESH] |Scotland/epidemiology[MESH] |State Medicine[MESH]A prospective cohort study of the safety of breast cancer surgery duri(epmc).pdf DeepDyve Pubget Overpricing